Psagot Value Holdings Ltd. - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 46 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 3.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Psagot Value Holdings Ltd. ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$01,0000.0%0.00%
Q2 2019$0
-100.0%
1,000
-96.8%
0.00%
-100.0%
Q1 2019$14,000
+40.0%
31,358
-1.0%
0.00%
Q4 2018$10,000
-54.5%
31,665
+3.9%
0.00%
-100.0%
Q3 2018$22,000
+69.2%
30,491
-1.4%
0.00%0.0%
Q2 2018$13,000
-13.3%
30,936
+5.6%
0.00%0.0%
Q1 2018$15,000
-25.0%
29,292
+0.3%
0.00%0.0%
Q4 2017$20,000
+5.3%
29,193
-10.4%
0.00%0.0%
Q3 2017$19,000
-26.9%
32,577
+2.9%
0.00%0.0%
Q2 2017$26,000
-13.3%
31,674
+43.6%
0.00%0.0%
Q1 2017$30,000
+200.0%
22,050
-0.9%
0.00%
Q4 2016$10,000
-23.1%
22,250
+0.9%
0.00%
-100.0%
Q3 2016$13,000
-7.1%
22,0500.0%0.00%0.0%
Q2 2016$14,000
-80.6%
22,050
-74.1%
0.00%
-66.7%
Q1 2016$72,000
-30.1%
85,242
-16.3%
0.00%
-25.0%
Q4 2015$103,0000.0%101,876
+17.0%
0.00%0.0%
Q3 2015$103,000
-56.9%
87,097
-28.9%
0.00%
-50.0%
Q2 2015$239,000
+86.7%
122,501
+70.3%
0.01%
+100.0%
Q1 2015$128,000
-3.0%
71,9290.0%0.00%0.0%
Q4 2014$132,000
-24.1%
71,9290.0%0.00%
-33.3%
Q3 2014$174,000
-33.8%
71,9290.0%0.01%
-33.3%
Q2 2014$263,000
-20.1%
71,9290.0%0.01%
-18.2%
Q1 2014$329,000
+13.4%
71,929
-3.4%
0.01%
+10.0%
Q4 2013$290,000
+161.3%
74,484
+202.7%
0.01%
+150.0%
Q3 2013$111,000
-8.3%
24,6050.0%0.00%
-20.0%
Q2 2013$121,00024,6050.01%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,178,440$5,397,0004.64%
GREAT POINT PARTNERS LLC 912,155$4,178,0002.18%
Camber Capital Management LP 2,000,000$9,160,0000.72%
Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) 703,443$3,222,0000.34%
MENORA MIVTACHIM HOLDINGS LTD. 836,078$3,829,0000.31%
FEDERATED HERMES, INC. 10,240,014$46,900,0000.16%
DELTEC ASSET MANAGEMENT LLC 109,473$501,0000.11%
Baillie Gifford 5,882,224$26,941,0000.06%
Allianz Asset Management GmbH 7,480,712$34,262,0000.04%
NJ State Employees Deferred Compensation Plan 40,000$183,0000.04%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders